Non-alcoholic fatty liver disease or NALFD is expected to become the next global epidemic (Sherif et al, 2015). NAFLD is defined as accumulation of lipids inside the hepatocytes exceeding 5% of the weight of the liver and in the absence of liver disease etiologies such as chronic viral hepatitis, medications that induce steatosis, significant alcohol consumption and other chronic liver diseases.
NAFLD is a benign condition but the disease can take a more serious form if it develops into non-alcoholic steatohepatitis, commonly known as NASH. The disease is expected to become the leading cause